Literature DB >> 2062368

Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation.

J P Issartel1, V Koronakis, C Hughes.   

Abstract

Haemolysin secreted by pathogenic Escherichia coli binds to mammalian cell membranes, disrupting cellular activities and lysing cells by pore-formation. It is synthesized as nontoxic prohaemolysin (proHlyA), which is activated intracellularly by a mechanism dependent on the cosynthesized HlyC. Haemolysin is one of a family of membrane-targeted toxins, including the leukotoxins of Pasteurella and Actinobacillus and the bifunctional adenylate cyclase haemolysin of Bordetella pertussis, which require this protoxin activation 1-5. HlyC alone cannot activate proHlyA, but requires a cytosolic activating factor6. Here we report the cytosolic activating factor is identical to the acyl carrier protein and that activation to mature toxin is achieved by the transfer of a fatty acyl group from acyl carrier protein to proHlyA. Only acyl carrier protein, not acyl-CoA, can promote HlyC-directed proHlyA acylation, but a range of acyl groups are effective.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062368     DOI: 10.1038/351759a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  91 in total

1.  Characterization of a Pseudomonas aeruginosa fatty acid biosynthetic gene cluster: purification of acyl carrier protein (ACP) and malonyl-coenzyme A:ACP transacylase (FabD).

Authors:  A J Kutchma; T T Hoang; H P Schweizer
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control.

Authors:  N Kondo; K Kuwahara-Arai; H Kuroda-Murakami; E Tateda-Suzuki; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

3.  Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.

Authors:  S C Kachlany; D H Fine; D H Figurski
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Isolation and characterization of Escherichia coli tolC mutants defective in secreting enzymatically active alpha-hemolysin.

Authors:  H Vakharia; G J German; R Misra
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

5.  Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles.

Authors:  C Hyland; L Vuillard; C Hughes; V Koronakis
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

6.  Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652.

Authors:  Christine Mitchell; Ling Gao; Donald R Demuth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Structural modification of acyl carrier protein by butyryl group.

Authors:  Bai-Nan Wu; Yong-Mei Zhang; Charles O Rock; Jie J Zheng
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  F Betsou; P Sebo; N Guiso
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.

Authors:  D Vagts; H P Dienes; P J Barth; H Ronneberger; K D Hungerer; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.